Martin Sandelin
About
In The Last Decade
Martin Sandelin
21 papers receiving 373 citations
Peers
Comparison fields: 5 of 69
- Pulmonary and Respiratory Medicine 115
- Oncology 113
- Immunology 97
- Molecular Biology 83
- Physiology 66
Countries citing papers authored by Martin Sandelin
This map shows the geographic impact of Martin Sandelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Sandelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Sandelin more than expected).
Fields of papers citing papers by Martin Sandelin
This network shows the impact of papers produced by Martin Sandelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Sandelin. The network helps show where Martin Sandelin may publish in the future.
Co-authorship network of co-authors of Martin Sandelin
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Sandelin. A scholar is included among the top collaborators of Martin Sandelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Sandelin. Martin Sandelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 13 | |
| 3 | 7 | |
| 4 | 17 | |
| 5 | 24 | |
| 6 | 15 | |
| 7 | 7 | |
| 8 | 10 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | Patients with Non-small Cell Lung Cancer Analyzed for EGFR: Adherence to Guidelines, Prevalence and Outcome. | 30 |
| 12 | 84 | |
| 13 | 57 | |
| 14 | The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy. | 1 |
| 15 | 1 | |
| 16 | 32 | |
| 17 | 17 | |
| 18 | 35 | |
| 19 | 6 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.